Story · Health Tech · Medicine & Biotech

AHA26: Cordio Medical’s voice-based heart failure analytic hits in pivotal trial

1 outlet · first reported by Medical Device Network 2d ago

Coverage, in order

  1. 2d ago
    Medical Device Network UK indie study
    AHA26: Cordio Medical’s voice-based heart failure analytic hits in pivotal trial

    With the pivotal results for HearO in hand, Cordio will now seek FDA clearance for the early heart failure tool, with a US market launch anticipated in 2027.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.